Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Gugliotta

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Leukemia & Lymphoma|March 23, 2010
Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Expert Review of Hematology|October 3, 2013
Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitorsGabriele Gugliotta, Fausto Castagnetti, Miriam Fogli, et al.
Leukemia Research|April 15, 2011
F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinibAnthony A Oyekunle, Fausto Castagnetti, Gabriele Gugliotta, et al.
Journal of Cellular Biochemistry|November 13, 2014
DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemiaElisa Leo, Manuela Mancini, Fausto Castagnetti, et al.
Leukemia|January 25, 2019
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overviewMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Drugs|April 9, 2014
First-line treatment of newly diagnosed elderly patients with chronic myeloid leukemia: current and emerging strategiesGabriele Gugliotta, Fausto Castagnetti, Michela Apolinari, et al.
Oncotarget|November 21, 2017
Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemiaManuela Mancini, Simona Soverini, Gabriele Gugliotta, et al.
Cellular Signalling|April 22, 2014
A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinibManuela Mancini, Elisa Leo, Virginia Campi, et al.
American Journal of Hematology|February 18, 2026
MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-UpAlessandro Broccoli, Enrico Derenzini, Lisa Argnani, et al.
The Oncologist|February 10, 2024
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous TransplantationAlessandro Broccoli, Lisa Argnani, Gabriele Gugliotta, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|March 23, 2010
Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'Gianantonio Rosti, Fausto Castagnetti, Gabriele Gugliotta, et al.
Expert Review of Hematology|October 3, 2013
Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitorsGabriele Gugliotta, Fausto Castagnetti, Miriam Fogli, et al.
Leukemia Research|April 15, 2011
F317L BCR-ABL1 kinase domain mutation associated with a sustained major molecular response in a CML patient on dasatinibAnthony A Oyekunle, Fausto Castagnetti, Gabriele Gugliotta, et al.
Journal of Cellular Biochemistry|November 13, 2014
DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemiaElisa Leo, Manuela Mancini, Fausto Castagnetti, et al.
Leukemia|January 25, 2019
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overviewMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.
Drugs|April 9, 2014
First-line treatment of newly diagnosed elderly patients with chronic myeloid leukemia: current and emerging strategiesGabriele Gugliotta, Fausto Castagnetti, Michela Apolinari, et al.
Oncotarget|November 21, 2017
Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemiaManuela Mancini, Simona Soverini, Gabriele Gugliotta, et al.
Cellular Signalling|April 22, 2014
A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinibManuela Mancini, Elisa Leo, Virginia Campi, et al.
American Journal of Hematology|February 18, 2026
MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-UpAlessandro Broccoli, Enrico Derenzini, Lisa Argnani, et al.
The Oncologist|February 10, 2024
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous TransplantationAlessandro Broccoli, Lisa Argnani, Gabriele Gugliotta, et al.
Pageof 9